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Almost a century ago, the 
experiments of Hans Spemann 
and Hilde Mangold on 
transplantation of cells between 
Xenopus embryos demonstrated 
that the body plan is determined 
by intricate communication 
between cells. Today, through 
genetic, molecular and 
biochemical analyses, we know 
the major signaling pathways 
that mediate these interactions 
and many of their molecular 
constituents, which are highly 
conserved in evolution. Despite 
mechanistic differences between 
the pathways, the general mode 
through which they function is 
similar. A diffusible signaling 
molecule — morphogen — is 
released from a restricted 
group of cells and spreads to 
define a concentration gradient. 
On reaching a responsive 
neighboring cell, the morphogen 
triggers an intracellular signaling 
pathway; the information is 
ultimately transmitted to the 
nucleus where it alters the 
program of gene expression. 
The receiving cells can respond 
differently to distinct levels of 
the morphogen they encounter, 
hence a single morphogen can 
lead to the induction of several 
cell fates, depending on their 
position within the tissue.
Because a morphogen can 
induce multiple different cell 
fates according to its level, a 
host of questions arises with 
respect to the quantitative 
nature of this signaling. 
The most cardinal issue to 
consider involves robustness: 
how are patterns generated 
in a reproducible fashion by 
morphogens, despite fluctuations 
in gene dosage, gene expression, 
temperature, and so on. The 
pathways guiding developmental 
Primer decisions need to be analyzed in quantitative terms, in order to 
describe the critical spatial and 
temporal parameters underlying 
establishment of the gradient, 
and to elucidate the mechanisms 
that restrict their fluctuations in 
a noisy environment. The two 
critical parameters to analyze 
include the shape of morphogen 
distribution in time and space, 
and the mechanism by which 
small concentration differences, 
defined by the continuous 
gradient of the morphogen, 
produce a bi-stable decision 
to express one set of target 
genes or another in the receiving 
cells. A combination of genetic 
and computational approaches 
is required to address these 
questions, but because most of 
the critical parameters cannot 
be accurately measured in vivo, 
if at all, combining the two 
approaches is not trivial. Over 
the past few years, a number of 
imaginative studies, which tackle 
these issues in different ways, 
have been carried out. 
Focusing on a single 
developmental pathway, 
namely the EGF receptor 
cascade in Drosophila, 
we will highlight different 
computational approaches that 
have been used to address 
central issues of morphogen 
distribution, robustness and 
threshold responses. A detailed 
description of this pathway is 
provided in Figure 1.
Determining the shape of the 
Gurken morphogen gradient in 
the ovary
In the Drosophila ovary, the 
activation profile of EGF receptor 
shapes the polarity of the egg 
chamber and the resulting 
polarity of the embryo. The 
EGF ligand that functions in 
this context is Gurken (Grk), 
which is made in the germline. 
At this stage, ~1,000 follicle 
cells surround the oocyte, 
and their patterning along the 
dorso- ventral axis by differential 
levels of EGF receptor activation 
determines the polarity of the 
egg chamber. The grk mRNA 
is anchored around the oocyte 
nucleus, which is located in 
the dorsal-anterior corner and thus provides a local source of 
Grk protein. Upon processing 
and secretion of the Grk 
protein, it is distributed in the 
extracellular milieu, triggering 
EGF receptor activation in 
adjacent follicle cells. The 
transcriptional responses to 
EGF receptor activation include 
induction of target genes, as 
well as repression of other 
genes in regions of prominent 
activation. The position of these 
response domains extends over 
60% of the field of follicle cells 
away from the oocyte nucleus, 
indicating that the distribution 
of biologically  active ligand is 
broad. But while Grk protein can 
be visualized after endocytosis 
into the receiving cells, the 
precise shape and spread of 
the biologically active Grk 
molecules cannot be determined 
microscopically because of 
detection limitations. 
Can computational analysis 
help in deriving key properties 
of the gradient? A molecule 
that spreads by diffusion in 
one dimension, and is subject 
to simple (linear) degradation, 
approaches a steady state 
profile that decays exponentially. 
The decay rate of this profile is 
characterized by a single decay 
length, λ, given by the ratio 
between the diffusion coefficient 
and degradation rate. This 
single decay length controls 
most of the properties of the 
gradient. For example, it defines 
the difference in concentration 
between any two positions 
in the field. The decay length 
also controls the sensitivity of 
the gradient to perturbations 
in the rate of morphogen 
production, diffusion coefficient 
or degradation rate. Measuring 
the decay length can thus be 
used to predict the sensitivity 
of the gradient to different 
perturbations. 
Conversely, if the gradient 
cannot be measured directly, its 
decay length could be derived 
by monitoring the sensitivity to 
different perturbations. Such 
an approach was proposed 
recently by Shvartsman and 
colleagues [1], and used to 
characterize the Grk gradient in 
the Drosophila egg chamber. In 
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system required more detailed 
derivation of the shape of 
the gradient, which deviated 
somewhat from a simple 
exponential. Importantly, the 
shape was similarly dependent 
on a single parameter, its decay 
length, given again by the ratio 
of morphogen diffusion and 
degradation. Moreover, because 
Grk degradation occurs mostly 
by endocytosis, it was possible 
to express the decay length 
as a function of the different 
parameters of the system, and to 
provide a quantitative prediction 
for the sensitivity of the gradient 
to changes in the levels of these 
parameters, such as the rate 
of morphogen production and 
the amount or activity of EGF 
receptor. 
By altering the level of 
EGF receptor expression in a 
quantitatively controlled manner, 
and measuring the resulting 
expression domain of one of 
the EGF receptor targets in the 
follicle cells, it was found that 
the Grk gradient decays over a 
distance that is about a third of 
the patterned field, of length L, 
so that L/λ ~ 3. This implies that 
the cells furthest away from the 
source of Grk encounter 10% of 
the maximal level, and the known 
thresholds of gene expression 
induced by it are located in 
regions encountering 60% or 
20% of the activity. Thus, the 
differences in concentration of 
Grk are informative and effective 
throughout the patterned field 
(Figure 2). 
This relatively slow decay 
raises intriguing questions 
about the interpretation and 
robustness of the gradient. First, 
because several thresholds of 
gene expression are defined 
in a relatively shallow domain, 
a highly sensitive and precise 
downstream signaling is required 
to define multiple response 
thresholds. Second, shallow 
gradients are expected to be 
highly dependent on the rate 
of morphogen production. 
For example, in the absence 
of additional feedbacks, flies 
heterozygous for grk will secrete 
the ligand at half the efficiency 
of wild type, resulting in gradient Figure 1. The EGF receptor 
pathway in Drosophila.
Four activating ligands 
have been identified; three 
are produced as inactive 
transmembrane precur-
sors, which generate an 
active secreted ligand 
upon processing. Spitz is 
the major ligand and func-
tions in most cases where 
the pathway is activated, 
Keren plays only a minor 
redundant role, and Gurken 
is usd exclusively during 
oogenesis. The fourth lig-
and, Vein, is produced as a 
secreted molecule, and is 
a weaker activating ligand 
used either to enhance sig-
naling by other ligands or 
in distinct situations such 
as muscle patterning. The 
three membrane-anchored 
ligands are retained in the 
ER, and processed, follow-
ing trafficking by the dedi-
cated chaperone protein 
Star, to a late compartment 
in the secretory pathway. Here, the ligands encounter Rhomboids, serine proteases 
which cleave the ligand precursors within the transmembrane domain to release the 
active, secreted form. Rhomboids also cleave and inactivate Star, attenuating the level 
of cleaved ligand that is produced. Within a receiving cell, the ligands encounter the 
EGF receptor, which upon dimerization triggers the canonical Sos/Ras/Raf/MEK/MAP 
kinase pathway. The cardinal transcriptional output of the pathway is mediated by the 
ETS protein Pointed, which is either phosphorylated by MAP kinase to produce an ac-
tive transcriptional activator (PointedP2), or transcriptionally induced by MAP kinase 
to produce a constitutive transcriptional activator (PointedP1). The ETS protein Yan 
acts as a constitutive repressor, which competes for Pointed-binding sites and can 
be removed from the nucleus and degraded upon phosphorylation by MAP kinase. 
Several negative regulators keep the pathway in check. Especially important is a group 
of inducible repressive elements, which constitute a negative feedback loop. Argos is 
a secreted molecule, which sequesters the ligand Spitz, Sprouty attenuates signaling 
within the receiving cell, and Kekkon is a transmembrane protein forming a non-func-
tional heterodimer with the receptor. 
Current Biologythat is 50% lower than that in 
wild  type. Ventral thresholds 
normally located at ~20% Grk 
level will consequently be shifted 
to the dorsal side of the egg 
chamber, while those located 
at the dorsal side will not be 
activated at all. It would be 
interesting to experimentally 
measure the sensitivity of 
the different thresholds to 
quantitative perturbations in 
grk levels, to examine whether 
additional mechanisms function 
to improve the robustness of 
the system. A similar analysis of 
the Bicoid gradient in the early 
Drosophila embryo has shown 
that an additional mechanism 
acts to ensure robustness, 
and suggests that the gradient 
is decoded before it reaches 
steady state [2]. Argos provides robustness
A mechanism that improves the 
robustness of the EGF receptor 
activation gradient has been 
described for another patterning 
system, one that acts later than 
the Grk system described above 
to shape the dorso- ventral 
axis of the Drosophila embryo. 
The EGF ligand that functions 
in this setting is Spitz (Spi), 
which is released from a single 
row of cells situated at the 
embryonic ventral midline. Spi 
diffuses to generate a gradient 
of EGF receptor activation in the 
adjacent cell rows, and triggers 
target genes through MAP kinase 
induction of pointedP1 (pntP1) 
expression. The spatial domain 
of pntP1 induction is confined to 
two to three cell rows on each 
side of the midline, and remains 
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Figure 2. Quantitative description of morphogen profile.
(A) A model of morphogen in one dimension. The morphogen is secreted by a localized 
source, diffuses away from it and is subject to linear degradation. Shown is the expo-
nential profile attained at steady state (note the logarithmic scale). Distinct cell-fates 
at a distance ∆x are defined according to two concentration thresholds (L1, and L2). 
In response to perturbation in the morphogen production rate, the profile shifts by a 
constant distance δx (dashed line). This shift is proportional to the decay rate of the 
profile. Accordingly, the quantitative shape of the profile can be predicted by simply 
measuring this shift. (B) A gradient of EGF receptor (EGFR) activation in the Drosophila 
egg chamber. The kekkon gene is expressed at high levels of activation in the follicle 
cells, whereas pipe is repressed at high and intermediate levels of EGF receptor acti-
vation, and expressed only in regions of lower EGF receptor activation. The activation 
and repression thresholds are predicted to correspond to 60% and 20% of the maximal 
EGF receptor activation, respectively. (C) Cross-section through the egg, showing the 
different expression domains of kekkon and pipe. The oocyte nucleus is located at the 
dorsal-anterior corner. (D) Side view of the expression domains of kekkon and pipe. robust to alterations in the level 
of ligand or the receptor, as 
revealed by heterozygocity or 
overexpression studies. 
What mechanism ensures 
that this patterning is robust? A 
key element in modulating the 
response is the secreted protein 
Argos (Aos), which is encoded 
by a target gene of PntP1 in the 
ventral ectoderm, and serves to 
attenuate EGF receptor signaling. 
Deletion of the aos gene leads 
to significant expansion of EGF 
receptor- dependent expression 
domains. Because Aos contains 
an EGF domain, it was initially 
assumed that Aos blocks EGF 
receptor. It was further assumed 
that Aos is widely diffusible, thus 
able to block EGF receptor far 
from the site of Aos synthesis. 
This mechanism of action, however, cannot explain the 
robustness of the system. 
Quantitative analysis of the 
system by Shvartsman and 
colleagues [3] has provided 
an alternative mode for 
repression by Aos. Again, the 
only measurable parameters 
were the borders of target gene 
expression in the wild- type 
situation and upon removal of 
aos. Shvartsman’s group tested 
which parameters would be 
consistent with these patterns, 
and found that Aos could 
generate the required signaling 
profile if it acts locally. The 
assumption was that Aos may 
actually attenuate EGF receptor 
signaling by sequestering 
the ligand, rather than the 
receptor. Detailed biochemical 
measurements by Lemmon’s group [4] have shown that Aos 
and Spi do indeed interact avidly. 
The mechanistic implication is 
that the long-range effect of Aos 
on EGF receptor signaling can 
be exerted simply by forming a 
‘sink’ for the ligand close to the 
site of Aos production, to reduce 
the effective level of ligand 
that will diffuse. This model is 
rewarding, not only because 
it restricts long- range effects 
to the distribution of Spi, but 
also because it may provide a 
mechanism to selectively inhibit 
EGF receptor signaling by some 
of the ligands but not others.
Can this feedback loop of 
Aos explain the robustness of 
the patterning? Further analysis 
of this system had shown 
that, to account for maximal 
robustness, the decay length 
of Spi (in the absence of Aos) 
must be three  to four cells. The 
local reduction in active Spi 
levels at the position of Aos 
expression, close to the site of 
Spi production, may generate 
a biphasic distribution profile 
of Spi and thus facilitates the 
robustness of the gradient 
[3]. This is consistent with a 
mechanism of ‘self-enhanced 
ligand degradation’, which we 
[5] have shown contributes to 
the robustness to fluctuations in 
ligand level, and generation of 
a reproducible profile of ligand 
distribution. 
Threshold responses by 
zero- order ultra sensitivity
Once the distribution profile 
of the ligand is set, the cells 
respond by triggering the 
expression of target genes 
with distinct thresholds. 
How cells can sense small 
differences in morphogen level 
to generate precise thresholds 
of gene expression is one 
of the major open questions 
in developmental biology. 
We examined this issue in 
the context of EGF receptor 
signaling in the embryonic 
ventral ectoderm. In order to 
study a direct readout of MAP 
kinase activation, rather than a 
transcriptional response which 
may already encompass several 
steps of information processing, 
we followed the degradation of 
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(A) In a wild-type embryo (stage 10), the activating ligand Spi emanates from the ventral 
midline (arrowhead), triggering EGF receptor in the adjacent cells, and leading to grad-
ed activation of MAP kinase that is detected with dpERK antibodies (red). (B) Within the 
domain of MAP kinase activation (dashed white line), the degradation pattern of Yan 
(green, full line) at the same stage shows a much more restricted and sharp response. 
(C) A classical zero-order hypersensitivity model, showing the reversible conversion of 
a substrate between two states, and the dependence of the final product only on the 
difference between the rate of opposing enzymatic reactions. (D) In the case of the 
Yan degradation network, in addition to phosphorylation by MAP kinase (MAPK) and 
dephosphorylation by unknown proteases, aspects such as synthesis and degradation 
have to be considered. Similar to the classical model, a switch-like behavior is gener-
ated when the substrate is in excess with respect to the dissociation constants for the 
two opposing enzymes.the ETS repressor Yan, which 
is uniformly transcribed at this 
stage. In response to MAP 
kinase phosphorylation, the 
Yan protein undergoes nuclear 
export and degradation. A sharp 
threshold of degradation, which 
is sensitive to the level of MAP 
kinase activity, is observed one 
to two rows of cells from the 
ventral midline (Figure 3).
A number of mechanisms 
may account for the generation 
of this sharp threshold. A 
threshold could be generated, 
for example, by a cooperative 
effect, if multiple MAP 
kinase- dependent reactions are 
required for Yan degradation. 
Alternatively, a putative positive 
feedback that facilitates either 
MAP kinase activation or Yan 
degradation could also lead to 
such a threshold response. Yet 
a third mechanism, ‘zero- order 
ultrasensitivity’, has been 
proposed, whereby threshold 
is generated by opposing 
modification reactions, both of 
which function at the zero-order 
regime. We used computational 
analysis to define which 
perturbations will be most 
informative for distinguishing 
between these qualitatively 
different mechanisms. This 
analysis suggested examining 
the phenotypes of embryos over-
expressing Yan protein, followed 
by characterization of both the 
final pattern of Yan degradation, 
as well as the time to reach this 
pattern. Further experiments 
indicated that reactions occur 
at the zero- order regime [6], 
suggesting threshold is indeed 
generated through a mechanism 
akin to the zero-order 
hypersensitivity model proposed 
by Koshland and Goldbeter. In 
essence, a substrate which is 
in excess is shifting between 
two reversible states, for 
example, phosphorylated 
and dephosphorylated. It will 
accumulate exclusively on one 
side or the other, depending 
simply on the difference between 
the forward and backward 
rates, thus forming a sensitive 
threshold (Figure 3). Such a mechanism could also be 
considered for transcriptional 
factors, which may require a 
covalent modification such as 
phosphorylation for their activity.
In conclusion, how 
developmental signaling 
pathways produce and respond 
to signals in a reproducible 
manner, irrespective of genetic 
and environmental fluctuations, 
is a major open question in 
understanding pattern formation. 
Detailed knowledge of the 
components of each pathway 
is available, as well as a variety 
of ways in which each circuitry 
can be tweaked and monitored. 
Imaginative modeling can 
now provide new mechanistic 
outlooks on the design principles 
of each circuit.
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